30.65
price up icon2.17%   0.65
after-market Handel nachbörslich: 30.65
loading
Schlusskurs vom Vortag:
$30.00
Offen:
$30.01
24-Stunden-Volumen:
515.39K
Relative Volume:
1.90
Marktkapitalisierung:
$947.46M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-5.5931
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
+6.39%
1M Leistung:
+29.11%
6M Leistung:
+50.91%
1J Leistung:
+71.52%
1-Tages-Spanne:
Value
$29.55
$30.67
1-Wochen-Bereich:
Value
$28.29
$30.67
52-Wochen-Spanne:
Value
$14.76
$30.67

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name
Firmenname
Fulgent Genetics Inc
Name
Telefon
626-350-0537
Name
Adresse
4399 SANTA ANITA AVE, EL MONTE
Name
Mitarbeiter
1,313
Name
Nächster Verdiensttermin
2025-08-01
Name
Neueste SEC-Einreichungen
Name
FLGT's Discussions on Twitter

Vergleichen Sie FLGT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
FLGT
Fulgent Genetics Inc
30.65 927.37M 290.71M -163.43M 11.70M -5.48
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
586.07 220.72B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
226.98 160.62B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
752.14 57.96B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
153.60 42.88B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
228.18 38.30B 15.90B 1.28B 2.21B 7.2842

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-05 Hochstufung UBS Neutral → Buy
2023-12-07 Eingeleitet UBS Neutral
2022-12-08 Herabstufung Piper Sandler Overweight → Neutral
2022-11-18 Eingeleitet Raymond James Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-02-04 Fortgesetzt Piper Sandler Overweight
2021-08-05 Fortgesetzt Credit Suisse Underperform
2021-01-08 Herabstufung Credit Suisse Neutral → Underperform
2020-11-24 Herabstufung BTIG Research Buy → Neutral
2020-08-20 Eingeleitet Oppenheimer Outperform
2020-05-29 Eingeleitet BTIG Research Buy
2019-11-05 Hochstufung Piper Jaffray Neutral → Overweight
2018-03-01 Herabstufung Piper Jaffray Overweight → Neutral
2017-11-07 Herabstufung Raymond James Outperform → Mkt Perform
Alle ansehen

Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten

pulisher
Nov 24, 2025

Have Insiders Sold Fulgent Genetics Shares Recently? - simplywall.st

Nov 24, 2025
pulisher
Nov 22, 2025

Fulgent Genetics (NASDAQ:FLGT) COO Sells $291,000.00 in Stock - MarketBeat

Nov 22, 2025
pulisher
Nov 21, 2025

[Form 4] Fulgent Genetics, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Can Fulgent Genetics Inc. (7F0) stock test all time highsMarket Performance Summary & Daily Momentum Trading Reports - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How Fulgent Genetics Inc. (7F0) stock reacts to new regulationsJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why Fulgent Genetics Inc. stock appeals to analysts2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 17:53:16 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How analysts revise price targets for Fulgent Genetics Inc. (7F0) stockJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Fulgent Genetics Inc. (7F0) stock outperform value peers2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Fulgent Genetics Inc. (7F0) stock among top earnings playsQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Fulgent Genetics Inc. stock resilient to inflationWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Fulgent Genetics Inc. (7F0) stock resist broad market declinesWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Does Fulgent Genetics Inc. (7F0) stock trade below intrinsic valueOptions Play & Real-Time Volume Spike Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Fulgent Genetics Inc. stock resist sector downturns2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Momentum divergence signals in Fulgent Genetics Inc. chartMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Multi factor analysis applied to Fulgent Genetics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Can Fulgent Genetics Inc. stock resist market sell offsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Campbell & CO Investment Adviser LLC Purchases 9,217 Shares of Fulgent Genetics, Inc. $FLGT - MarketBeat

Nov 17, 2025
pulisher
Nov 17, 2025

Fulgent Genetics (FLGT) Price Target Increased by 32.90% to 34.34 - Nasdaq

Nov 17, 2025
pulisher
Nov 16, 2025

Is Fulgent Genetics Inc. stock undervalued vs historical averagesJuly 2025 Patterns & Community Supported Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What dividend safety score for Fulgent Genetics Inc. stockWatch List & Weekly Momentum Picks - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will Fulgent Genetics Inc. stock benefit from upcoming earnings reportsJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Fulgent Genetics (NASDAQ: FLGT) Developments and S&P 500 Market - Kalkine Media

Nov 16, 2025
pulisher
Nov 16, 2025

Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Nov 16, 2025

Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$190.58
price down icon 0.35%
diagnostics_research LH
$265.31
price down icon 0.12%
diagnostics_research WAT
$399.54
price up icon 1.41%
diagnostics_research MTD
$1,470.14
price up icon 1.22%
$238.58
price up icon 3.45%
diagnostics_research IQV
$228.18
price up icon 1.46%
Kapitalisierung:     |  Volumen (24h):